|
|
Volumn 12, Issue 3, 2014, Pages 196-199
|
|
What is the best neoadjuvant regimen prior to oesophagectomy: Chemotherapy or chemoradiotherapy?
a
|
|
Author keywords
Neoadjuvant therapy; Oesophageal cancer
|
|
Indexed keywords
ARABINOSIDE;
CARBOPLATIN;
CISPLATIN;
EPIRUBICIN;
ETOPOSIDE;
FLUOROURACIL;
FOLINIC ACID;
IRINOTECAN;
PACLITAXEL;
ANTINEOPLASTIC AGENT;
ADJUVANT CHEMORADIOTHERAPY;
ADJUVANT CHEMOTHERAPY;
ANASTOMOSIS LEAKAGE;
ARTICLE;
CANCER SURVIVAL;
COMPUTER ASSISTED TOMOGRAPHY;
DIARRHEA;
DISEASE FREE SURVIVAL;
ENDOSCOPIC ECHOGRAPHY;
ESOPHAGITIS;
ESOPHAGUS CANCER;
ESOPHAGUS RESECTION;
HEALTH CARE COST;
HUMAN;
MORBIDITY;
MORTALITY;
MULTIPLE CYCLE TREATMENT;
NAUSEA AND VOMITING;
NEUTROPENIA;
OVERALL SURVIVAL;
PERIOPERATIVE PERIOD;
PEROPERATIVE COMPLICATION;
POSITRON EMISSION TOMOGRAPHY;
POSTOPERATIVE COMPLICATION;
PRIORITY JOURNAL;
PROGRESSION FREE SURVIVAL;
RADIATION DOSE;
SEPSIS;
TREATMENT OUTCOME;
TREATMENT RESPONSE;
ADJUVANT THERAPY;
AGED;
ESOPHAGEAL NEOPLASMS;
MALE;
PRACTICE GUIDELINE;
AGED;
ANTINEOPLASTIC AGENTS;
CHEMORADIOTHERAPY, ADJUVANT;
CHEMOTHERAPY, ADJUVANT;
ESOPHAGEAL NEOPLASMS;
ESOPHAGECTOMY;
HUMANS;
MALE;
NEOADJUVANT THERAPY;
PRACTICE GUIDELINES AS TOPIC;
|
|
EID: 84896731251
PISSN: 17439191
EISSN: 17439159
Source Type: Journal
DOI: 10.1016/j.ijsu.2013.12.005 Document Type: Article |
|
Times cited : (11)
|
|
References (8)
|
